Second messengers and Lowe syndrome.

5-HT receptors: subtypes and second messengers.

Second messengers of insulin action.

Generation and functions of second messengers microdomains.

Second messengers in thrombin-stimulated bone resorption.

Calcium mobilizing second messengers derived from NAD.

Introduction: Second messengers in neural development.

The oculo-cerebral-renal syndrome of Lowe.

Clinical utility gene card for: Lowe syndrome.

Second messengers and affective illness. Focus on the phosphoinositide cycle.

Second messengers in cholinergic-induced convulsions and neuronal injury.

Extracellular matrix contraction by fibroblasts: peptide promoters and second messengers.

Brain clock driven by neuropeptides and second messengers.

Involvement of second messengers and protein phosphorylation in astrocyte swelling.

Cell adhesion molecules, second messengers and axonal growth.

Radiological cases of the month. Lowe (oculocerebrorenal) syndrome.

Gonadotrophin abnormalities in an infant with Lowe syndrome.

Lowe syndrome: a single center's experience in Korea.

Delayed vitreous haemorrhage after paediatric cataract surgery in Lowe syndrome.

Primary cilium and sonic hedgehog signaling during neural tube patterning: role of GPCRs and second messengers.

Presynaptic dopamine autoreceptors and second messengers controlling tyrosine hydroxylase activity in rat brain.

Galanin receptors and their second messengers in the lumbar dorsal spinal cord.

Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells.

Autoradiographic localization of binding sites for second messengers on neurones and astrocytes of cultured rat cerebellum.

Second messengers, steroids and signaling cascades: Crosstalk in sperm development and function.

Suggest Documents

5-HT receptors: subtypes and second messengers.

Second messengers of insulin action.

Generation and functions of second messengers microdomains.

Second messengers in thrombin-stimulated bone resorption.

Calcium mobilizing second messengers derived from NAD.

Introduction: Second messengers in neural development.

The oculo-cerebral-renal syndrome of Lowe.

Clinical utility gene card for: Lowe syndrome.

Second messengers and affective illness. Focus on the phosphoinositide cycle.

Second messengers in cholinergic-induced convulsions and neuronal injury.

Extracellular matrix contraction by fibroblasts: peptide promoters and second messengers.

Brain clock driven by neuropeptides and second messengers.

Involvement of second messengers and protein phosphorylation in astrocyte swelling.

Cell adhesion molecules, second messengers and axonal growth.

Radiological cases of the month. Lowe (oculocerebrorenal) syndrome.

Gonadotrophin abnormalities in an infant with Lowe syndrome.

Lowe syndrome: a single center's experience in Korea.

Delayed vitreous haemorrhage after paediatric cataract surgery in Lowe syndrome.

Primary cilium and sonic hedgehog signaling during neural tube patterning: role of GPCRs and second messengers.

Presynaptic dopamine autoreceptors and second messengers controlling tyrosine hydroxylase activity in rat brain.

Galanin receptors and their second messengers in the lumbar dorsal spinal cord.

Functional expression of human 5-HT1A receptors and differential coupling to second messengers in CHO cells.

Autoradiographic localization of binding sites for second messengers on neurones and astrocytes of cultured rat cerebellum.

Second messengers, steroids and signaling cascades: Crosstalk in sperm development and function.

Second messengers and Lowe syndrome.

Recommend Documents

Follow Us